PERSISTENT2023-04-012023-06-30 PERSISTENT2023-04-012023-06-30in-bse-fin:OneOperatingExpenses01Member PERSISTENT2023-04-012023-06-30in-bse-fin:OneOperatingExpenses02Member PERSISTENT2023-04-012023-06-30in-bse-fin:OneOperatingExpenses03Member PERSISTENT2023-04-012023-06-30in-bse-fin:OneOperatingExpenses04Member PERSISTENT2023-04-012023-06-30in-bse-fin:OneOperatingExpenses05Member PERSISTENT2023-04-012023-06-30in-bse-fin:OneOperatingExpenses06Member PERSISTENT2023-04-012023-06-30in-bse-fin:OneOperatingExpenses07Member PERSISTENT2023-04-012023-06-30in-bse-fin:OneOperatingExpenses08Member PERSISTENT2023-04-012023-06-30in-bse-fin:OneOperatingExpenses09Member PERSISTENT2023-04-012023-06-30in-bse-fin:OneOperatingExpenses10Member PERSISTENT2023-06-30 PERSISTENT2023-04-012023-06-30in-bse-fin:OneReportableSegmentRevenue01Member PERSISTENT2023-04-012023-06-30in-bse-fin:OneReportableSegmentRevenue02Member PERSISTENT2023-04-012023-06-30in-bse-fin:OneReportableSegmentRevenue03Member PERSISTENT2023-04-012023-06-30in-bse-fin:OneReportableSegmentResults01Member PERSISTENT2023-04-012023-06-30in-bse-fin:OneReportableSegmentResults02Member PERSISTENT2023-04-012023-06-30in-bse-fin:OneReportableSegmentResults03Member PERSISTENT2023-04-012023-06-30in-bse-fin:OneReportableSegmentAssets01Member PERSISTENT2023-04-012023-06-30in-bse-fin:OneReportableSegmentAssets02Member PERSISTENT2023-04-012023-06-30in-bse-fin:OneReportableSegmentAssets03Member PERSISTENT2023-04-012023-06-30in-bse-fin:OneReportableSegmentLiabilities01Member PERSISTENT2023-06-30in-bse-fin:OneReportableSegmentLiabilities01Member PERSISTENT2023-04-012023-06-30in-bse-fin:OneReportableSegmentLiabilities02Member PERSISTENT2023-06-30in-bse-fin:OneReportableSegmentLiabilities02Member PERSISTENT2023-04-012023-06-30in-bse-fin:OneReportableSegmentLiabilities03Member PERSISTENT2023-06-30in-bse-fin:OneReportableSegmentLiabilities03Member PERSISTENT2023-04-012023-06-30in-bse-fin:OneItemsThatWillNotBeReclassifiedToProfitAndLoss01Member PERSISTENT2023-04-012023-06-30in-bse-fin:OneItemsThatWillBeReclassifiedToProfitAndLoss01Member PERSISTENT2023-04-012023-06-30in-bse-fin:OneItemsThatWillBeReclassifiedToProfitAndLoss02Member iso4217:INRxbrli:purexbrli:sharesiso4217:INRxbrli:shares 533179 PERSISTENT NOTLISTED Persistent Systems Limited Equity 2023-04-01 2024-03-31 2023-07-20 2023-06-26 INR Millions First quarter 08:00:00 15:30:00 2023-07-20 2023-07-20 Not applicable Multi segment 2023-04-01 2023-06-30 Audited Consolidated 23211750000.00 216470000.00 23428220000.00 0.00 0.00 0.00 16312080000.00 125970000.00 763280000.00 3156400000.00 20357730000.00 3070490000.00 0.00 3070490000.00 914020000.00 -131210000.00 782810000.00 0.00 2287680000.00 0.00 0.00 0.00 0.00 2287680000.00 -46070000.00 2241610000.00 2287680000.00 0.00 -46080000.00 0.00 769250000.00 10 30.50 29.75 0.00 0.00 30.50 29.75 0.00 0.01 0.00 1.The audited condensed interim standalone financial statements for the quarter ended June 30, 2023, have been taken on record by the Board of Directors at its meeting held on July 20, 2023 as recommended by the Audit Committee at its meeting held on July 19, 2023. The statutory auditors have expressed an unmodified audit opinion. The information presented above is extracted from the audited condensed interim standalone financial statements. 2.The above standalone financial results have been prepared from the condensed interim standalone financial statements, which are prepared in accordance with Indian Accounting Standards ( Ind AS ), the provisions of the Companies Act, 2013 ( the Companies Act ), as applicable and guidelines issued by the Securities and Exchange Board of India ( SEBI ). The Ind AS are prescribed under Section 133 of the Companies Act read with Rule 3 of the Companies (Indian Accounting Standards) Rules, 2015 and amendments issued thereafter. All amounts included in the standalone financial results (including notes) are reported in millions of Indian rupees ( in INR Millions) except share and per share data, unless otherwise stated. 3.Prof. Deepak Phatak (DIN:00046205), Independent Director of the Company, tendered his resignation through his letter dated April 2, 2023 from the Board position upon reaching 75 years and confirmed that there were no material reasons for his resignation. Accordingly, Prof. Phatak ceased to be Independent Director effective from April 2, 2023. 4.On April 6, 2023, 500,000 (five hundred thousand only) equity shares of INR 10 each were allotted to the ESOP Trust at allotment price of INR 2,789 per equity share, aggregating to the total consideration of INR 1,394.50 Million. Consequent to this, the paid-up share capital of the Company is increased from 76.43 Million equity shares to 76.93 Million equity shares. Listing of the 500,000 shares on the stock exchanges is completed. 5.Dr. Ajit Ranade (DIN: 00918651) has been appointed as the Non-Executive Additional Director (Independent member) of the Company in the Board Meeting held on June 6, 2023. The members at the 33rd Annual General Meeting of the Company held on July 18, 2023, confirmed his appointment as the Non-Executive Director (Independent member) not liable to retire by rotation, to hold office for the term of 5 (five) consecutive years i.e., from June 6, 2023 to June 5, 2028. 6.CAPIOT Software Pte. Limited, Singapore (step down subsidiary) was struck off on April 6, 2023. 7.SCI Fusion 360 LLC, USA, (step down subsidiary) was dissolved with effective from May 31, 2023. 8.Youperience Limited, UK (step down subsidiary) was dissolved with effect from June 27, 2023. 9.In accordance with para 4 of notified Ind AS-108 “Operating Segments”, the Company has disclosed segment information only on the basis of consolidated financial results. 10.The investors are requested to visit the following website of the Company and stock exchanges for further details: Company's website: https://www.persistent.com/investors BSE Ltd: www.bseindia.com National Stock Exchange of India Ltd.: www.nseindia.com (Reversal) / Allowance for expected credit loss (net) 66060000.00 Advertisement, conference and sponsorship fees 35080000.00 Legal and professional fees 347250000.00 Miscellaneous expenses 227740000.00 Other Expenses 317620000.00 Purchase of software licenses 1520680000.00 Recruitment expenses 69400000.00 Rent 31280000.00 Training and seminars 39150000.00 Travelling and conveyance 502140000.00 Banking, Financial Services and Insurance (BFSI) 7736940000.00 Healthcare & Life Sciences 4309240000.00 Software, Hi-Tech and Emerging Industries 11165570000.00 23211750000.00 0.00 23211750000.00 Banking, Financial Services and Insurance (BFSI) 2994920000.00 Healthcare & Life Sciences 2067670000.00 Software, Hi-Tech and Emerging Industries 2583510000.00 7646100000.00 125970000.00 4666110000.00 2854020000.00 Banking, Financial Services and Insurance (BFSI) 5571800000.00 Healthcare & Life Sciences 3363010000.00 Software, Hi-Tech and Emerging Industries 14032010000.00 22966820000.00 45005390000.00 67972210000.00 Banking, Financial Services and Insurance (BFSI) 0.00 Healthcare & Life Sciences 0.00 Software, Hi-Tech and Emerging Industries 0.00 0.00 25525860000.00 25525860000.00 Remeasurements of the defined benefit liabilities / asset -16180000.00 -16180000.00 0.00 Effective portion of cash flow hedge (net of tax) 155700000.00 Exchange differences in translating the financial statements of foreign operations -185590000.00 -29890000.00 0.00